AI-Driven Small Molecule Discovery Leader

Atome; United States; On-site; USD 200,000 - 300,000; Full time

Job summary

Atome is seeking a Chief Scientific Officer for its Small Molecule Business located in the United States. This role requires extensive experience in drug R&D, emphasizing leadership and strategic partnerships.

The ideal candidate will hold a Ph.D. and possess 15+ years of experience in drug discovery, with a proven track record in leading scientific teams. Responsibilities include defining scientific strategy, overseeing portfolio management, and collaborating with AI teams to drive innovation.

Qualifications

• 15+ years of progressive experience in drug discovery and development with leadership roles.
• Proven history of leading scientific teams and delivering candidates into clinical development.
• Exceptional communication and presentation skills for diverse audiences.

Responsibilities

• Define and execute a comprehensive scientific strategy for small molecule research.
• Oversee the progression of internal and partnered assets, making data-driven decisions.
• Stay at the forefront of global trends in small molecule research and AI-enabled drug discovery.
• Lead and mentor a diverse team of scientists across various disciplines.
• Partner with AI teams to enhance experimental workflows.

Skills

Leadership

Scientific vision

Operational discipline

Communication skills

Strategic thinking

Collaboration

Education

Ph.D. in Medicinal Chemistry, Pharmacology, or related discipline

Job description

Atome is seeking a Chief Scientific Officer for its Small Molecule Business located in the United States. This role requires extensive experience in drug R&D, emphasizing leadership and strategic partnerships.

The ideal candidate will hold a Ph.D. and possess 15+ years of experience in drug discovery, with a proven track record in leading scientific teams. Responsibilities include defining scientific strategy, overseeing portfolio management, and collaborating with AI teams to drive innovation.